title: Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
authors: Transplant Unit, Santa Casa de Porto Alegre, Rs, Brazil.
authors: E
authors: E
authors: Keitel
authors: A E
authors: AE
authors: Bittar
authors: A
authors: A
authors: Losekann
authors: L
authors: L
authors: Deboni
authors: F
authors: F
authors: Ceretta
authors: J C
authors: JC
authors: Goldani
authors: V D
authors: VD
authors: Garcia
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage*; D016572:Cyclosporine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D016853:Muromonab-CD3 / Q000008:administration & dosage; D011183:Postoperative Complications / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D011241:Prednisone / Q000008:administration & dosage*; D015996:Survival Rate
chemical_list: D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone